Suchergebnisse - "Turner, Nicholas C"

PubPharm (177)

1

Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype

enthalten in: bioRxiv.org | 2024

von Fitzpatrick, A. | Iravani, M. | Mills, A. | +7

2

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant : ASCO Rapid Recommendation Update

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Burstein, H. | DeMichele, A. | Fallowfield, L. | +31

3

Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer

enthalten in: The Lancet. Oncology | 2024

von Browne, I. | André, F. | Chandarlapaty, S. | +2

4

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Jhaveri, K. | Bellet, M. | Turner, N. | +19

5

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer : Clinical and Biomarker Results

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Schmid, P. | Turner, N. | Barrios, C. | +25

6

Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Coakley, M. | Villacampa, G. | Sritharan, P. | +21

7

Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer

enthalten in: bioRxiv.org | 2024

von Safonov, A. | Marra, A. | Bandlamudi, C. | +31

8

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer

enthalten in: Cancer discovery | 2024

von Kingston, B. | Pearson, A. | Herrera-Abreu, M. | +14

9

The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment

enthalten in: Nature reviews. Clinical oncology | 2024

von Morrison, L. | Loibl, S. | Turner, N.

10

Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype

enthalten in: Nature communications | 2023

von Fitzpatrick, A. | Iravani, M. | Mills, A. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]